Biologics Fill Finish Services Market | Industry Analysis | Market Size

Biologics Fill Finish Services Market (3rd Edition) by Type of Packaging Containers (Ampoules, Cartridges, Syringes and Vials), Type of Biologics (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Others), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Large, Mid-Sized and Small), Key Therapeutic Areas (Autoimmune Disorders, Oncological Disorders, Infectious Diseases, Cardiovascular Disorders and Other Disorders), Geographical Regions (North America, Europe, Asia Pacific, MENA and Latin America): Industry Trends and Global Forecasts, 2022-2035

Lowest Price Guaranteed From USD 5,899
Published
November 2022
Pages
550
View Count
29444
Buy Now

Example Insights

Overview

In order to meet the anticipated future demand for biologics fill / finish services in the American and European markets, contract service providers based in these regions have made significant investments in accruing additional capacity for drug product manufacturing and fill / finish

-- Chief Commercial Officer, large-sized company

The advent of biologics marked the beginning of a new era in the pharmaceutical industry. Over time, the growing promise of biopharmaceuticals has captured the interest of various industry and academic stakeholders. Currently, more than 200 biologics are commercially available and over 10,000 candidates are under clinical evaluation. With the increasing demand and diversity of biologics, an increase in the demand for production capacity and aseptic fill / finish operations has been observed. Aseptic fill / finish refers to the process of filling the final drug products in sterile packaging containers (including vials, syringes, ampoules and cartridges). Of all the steps involved in the production of biologics, fill / finish is amongst the most critical steps and a heavily outsourced operation. In fact, even a minute error during the fill / finish process can lead to microbial contamination, which can subsequently result in the loss of drug product, production delays and, most importantly, pose risk to the patient’s health. As a result, various stakeholders are turning to contract service providers for their fill / finish related requirements and necessary infrastructure, to ensure the development of quality drug products.

With the growing pipeline of biologics, the demand for contract services for biologics development and biologics fill / finish has increased. Currently, close to 180 companies offer biologics fill / finish services. These stakeholders have taken several initiatives to expand their existing facilities and incorporate advanced technologies in order to meet the growing demand for fill / finish services, reduce cost of operation / increase efficiency, and comply to evolving safety and regulatory requirements. Additionally, the biopharmaceutical industry has witnessed substantial number of partnerships and collaborations between drug developers and fill / finish biopharmaceuticals service providers over the last few years. We believe that service providers are likely to continue undertaking similar initiatives to consolidate their presence in this field, distinguish themselves from the competition and cater to the diversified needs of their clientele. With outsourcing being increasingly accepted as a viable / beneficial business model and the anticipated growth in the biologics market, the opportunity for fill / finish biopharmaceuticals service providers is expected to grow at a steady pace over the coming years.

Scope of the Report

The “Biologics Fill / Finish Services Market (3rd Edition) by Type of Packaging Containers (Ampoules, Cartridges, Syringes and Vials), Type of Biologics (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Large, Mid-sized and Small), Key Therapeutic Areas (Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Infectious Diseases and Other Disorders), Geographical Regions (North America, Europe, Asia Pacific, Middle East and North Africa and Latin America): Industry Trends and Global Forecasts, 2022-2035” report features an extensive study on the biologics fill / finish service providers. The study features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. Amongst other elements, the report includes:

A summary of the key insights captured in our research, offering a high-level view on the likely evolution of the biologics fill / finish service providers market in the short to mid-term, and long term.
A general introduction to biopharmaceuticals and contract manufacturing, featuring a detailed discussion on the need for outsourcing within the biopharmaceutical industry and key operations outsourced by the biologics drug developers, including fill / finish. It also provides information on the key considerations for selecting a fill / finish service provider, along with the benefits and risks associated with outsourcing fill / finish operations.
A detailed review of the overall landscape of the companies offering fill / finish services for biopharmaceuticals / biologics, along with analyses based on a number of relevant parameters, such as year of establishment, company size, location of headquarters, location of fill / finish facilities, type of packaging container(s) used (ampoules, cartridges, syringes and vials), type of biologic(s) manufactured (antibody drug conjugates, antibodies, biosimilars, cell therapies, gene therapies, oligonucleotides, peptides / proteins, vaccines, viral products, and others), scale of operation (preclinical, clinical and commercial), type of additional drug product-related service(s) offered (lyophilization, labeling, quality testing, storage and distribution services) and including details relared to companies.
A detailed competitiveness analysis of the biologics fill / finish service providers headquartered in different geographies (North America, Europe, Asia-Pacific ad Rest of the World) and offering services across various packaging container(s), based on supplier strength (in terms of years of experience and company size), service strength (considering type of biologic(s) manufactured, scale of operation and type of packaging container(s) used) and service diversity (including number of additional drug product-related service(s) offered and number of facilities).
Elaborate profiles of key players based in North America, Europe and Asia-Pacific. Each profile provides an overview of the company, information on its service offerings, fill / finish facilities, financial information (if available), details on partnerships, expansions, recent awards and accolades, and an informed future outlook.
A detailed analysis of the various partnerships and collaborations established by stakeholders in this domain since 2013. It includes a brief description of the partnership models (including service agreement, service alliance, product integration agreement and joint venture and acquisition) adopted by stakeholders in this domain. Further, it comprises of analysis based on year of partnership, scale of operation, type of service(s) offered, type of biologic(s) involved, type of process(es) involved and location of the facilities / headquarters. It also highlights the most active players (in terms of number of partnerships) in the domain.
A detailed analysis of the expansions undertaken by various service providers to enhance biologics fill / finish capabilities, based on various parameters, including year of expansion, type of expansion, geographical location of the facility, type of packaging container(s) involved, scale of operation (as mentioned in the expansion terms), type of service(s) offered, type of biologic(s) involved, and expansion details (in terms of new area added to the existing facilities). It also highlights the most active players (in terms of number of instances) in the domain.
A comprehensive analysis of the global biologics fill / finish capacity, by taking into consideration the container processing capacities of various fill / finish service providers (as available on respective company websites). The global biopharmaceutical fill / finish capacity has been distributed across number of packaging units, type of packaging container (ampoules, cartridges, syringes and vials), company size of the manufacturer (small, mid-sized and large), scale of operation (preclinical / clinical and commercial) and location of headquarters (North America, Europe, Asia-Pacific and Middle East and North Africa) and location of fill / finish facility (North America, Europe, Asia-Pacific and Middle East and North Africa and Rest of the World).
An estimate of the annual demand for fill / finish for biologics (in terms of number of units of packaging container), based on various relevant parameters, such as target patient population, dosing frequency, dose strength, type of packaging container and volume of the packaging container of the abovementioned products.
An analysis on the key performance indicators of service providers based on the information available for top ten biopharmaceutical players on various public platforms, as well as inputs obtained from primary research.
A regional capability assessment framework, which compares the biologics fill / finish capability across key geographies, based on a number of parameters, such as the number of biologics fill / finish service providers, number of biologics fill / finish facilities, number of biologics fill / finish partnerships inked in that particular geographical region, number of facility expansions and installed biologic fill / finish capacity in that particular geographical region.
A discussion on the potential growth drivers for the biologics fill / finish services market, takes into consideration the opportunities associated with the growing biopharmaceutical pipeline, increase in outsourcing of fill / finish operations, rising focus on self-administration of drugs / therapies and opportunities in the Asia-Pacific region.
A case study focused on use of robotic systems in fill / finish operations. It provides a list of equipment used by the service providers (wherever specified) for fill / finish operations, highlighting the purpose of robotics in various manufacturing operations. It also includes a list of companies providing robots for use in manufacturing processes carried in the pharmaceutical sector
A case study on the use of ready-to-use packaging components in the aseptic fill / finish operations. It also provides a list of suppliers providing ready-to-use components.

One of the key objectives of this report was to estimate the current market size and the future opportunity in the biologics fill / finish services market over the coming 13 years. Based on multiple parameters, such as growth of the overall biopharmaceutical market, cost of goods sold, direct manufacturing costs, share of other manufacturing costs and outsourcing trends related to fill / finish operations, we have provided an informed estimate of the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. In order to provide a detailed future outlook, year-wise projections of the current and future opportunity have been further segmented on the basis of type of packaging containers (ampoules, cartridges, syringes and vials), type of biologics (antibodies, cell therapies, gene therapies, oligonucleotides, recombinant proteins, vaccines and other biologics), key therapeutic areas (autoimmune disorders, oncological disorders, cardiovascular disorders, infectious diseases and other disorders), scale of operation (preclinical / clinical and commercial), company size (large, mid-sized and small), and key geographical regions, (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America). To account for the uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

The opinions and insights presented in this report are backed by a deep understanding of key insights generated from both secondary and primary research. The perceptions presented in this study were also influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following industry and non-industry players:

Gregor Kawaletz (Chief Commercial Officer, IDT Biologika)
Matt Delaney (Vice President Business Development & Marketing, ‎Cytovance Biologics)
Purushottam Singnurkar (Research Director and Head of Formulation Development, Syngene International)
Ales Sima (Business Development Manager, Oncomed Manufacturing)
Amit Chandra (Technology Watch Manager, Yposkesi)
Jos Vergeest (International Business Developer, HALIX)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Frequently Asked Questions

What is fill finish?
Who are the key players offering biologics fill / finish services?
Where are biologics fill / finish facilities located?
What is the market share of ampoules, cartridges, vials, and syringes in fill / finsih?
What types of expansion initiatives are being undertaken by players in this domain?
What is the current demand for biologics fill / finish services?
What is the current and future market size for biologics fill / finish services?

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Biologics
3.3. Need for Outsourcing Biologics-related Operations
3.4. Introduction to Contract Manufacturing
3.5. Commonly Outsourced Operations in the Biopharmaceutical Industry
3.5.1. Biologics Fill / Finish Operations
3.6. Basic Guidelines for Selecting a Fill / Finish Service Provider
3.7. Advantages of Outsourcing Fill / Finish Operations
3.8. Risks and Challenges of Outsourcing Fill / Finish Operations

4. BIOLOGICS FILL / FINISH SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Biologics Fill / Finish Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Fill / Finish Facilities
4.2.5. Analysis by Type of Packaging Container(s) Used
4.2.6. Analysis by Type of Biologic(s) Manufactured
4.2.7. Analysis by Scale of Operation
4.2.8. Analysis by Additional Drug Product-related Services Offered
4.2.9. Biologics Fill / Finish Service Providers: Information on Fill / Finish Capacity

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology and Key Parameters

5.3. Biologics Fill / Finish Service Providers in North America
5.3.1. Players Offering Services for Ampoules
5.3.2. Players Offering Services for Cartridges
5.3.3. Players Offering Services for Syringes
5.3.4. Players Offering Services for Vials

5.4. Biologics Fill / Finish Service Providers in Europe
5.4.1. Players Offering Services for Ampoules
5.4.2. Players Offering Services for Cartridges
5.4.3. Players Offering Services for Syringes
5.4.4. Players Offering Services for Vials

5.5. Biologics Fill / Finish Service Providers in Asia-Pacific and Rest of the World
5.5.1. Players Offering Services for Ampoules
5.5.2. Players Offering Services for Cartridges
5.5.3. Players Offering Services for Syringes
5.5.4. Players Offering Services for Vials

6. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. AbbVie Contract Manufacturing
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Financial Information
6.2.4. Recent Developments and Future Outlook

6.3. BioPharma Solutions
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. BioReliance
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Financial Information
6.4.4. Recent Developments and Future Outlook

6.5. Catalent Biologics
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Financial Information
6.5.4. Recent Developments and Future Outlook

6.6. Patheon
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Financial Information
6.6.4. Recent Developments and Future Outlook

6.7. Charles River Laboratories
6.7.1. Company Overview
6.7.2. Fill / Finish Related Services
6.7.3. Financial Information
6.7.4. Recent Developments and Future Outlook

7. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN EUROPE
7.1. Chapter Overview
7.2. Boehringer Ingelheim BioXcellence
7.2.1. Company Overview
7.2.2. Service Portfolio
7.2.3. Financial Information
7.2.4. Recent Developments and Future Outlook

7.3. Lonza
7.3.1. Company Overview
7.3.2. Service Portfolio
7.3.3. Financial Information
7.3.4. Recent Developments and Future Outlook

7.4. Pierre Fabre
7.4.1. Company Overview
7.4.2. Service Portfolio
7.4.3. Financial Information
7.4.4. Recent Developments and Future Outlook

7.5. Recipharm
7.5.1. Company Overview
7.5.2. Service Portfolio
7.5.3. Financial Information
7.5.4. Recent Developments and Future Outlook

7.6. Wacker Biotech
7.6.1. Company Overview
7.6.2. Service Portfolio
7.6.3. Financial Information
7.6.4. Recent Developments and Future Outlook

7.7. Fareva
7.7.1. Company Overview
7.7.2. Fill / Finish Related Services
7.7.3. Recent Developments and Future Outlook

7.8. Fresenius Kabi
7.8.1. Company Overview
7.8.2. Fill / Finish Related Services
7.8.3. Financial Information
7.8.4. Recent Developments and Future Outlook

7.9. Glaxo SmithKline
7.9.1. Company Overview
7.9.2. Fill / Finish Related Services
7.9.3. Financial Information
7.9.4. Recent Developments and Future Outlook

8. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC
8.1. Chapter Overview
8.2. Asymchem
8.2.1. Company Overview
8.2.2. Service Portfolio
8.2.3. Financial Information
8.2.4. Recent Developments and Future Outlook

8.3. Samsung Biologics
8.3.1. Company Overview
8.3.2. Service Portfolio
8.3.3. Financial Information
8.3.4. Recent Developments and Future Outlook

8.4. Syngene
8.4.1. Company Overview
8.4.2. Service Portfolio
8.4.3. Financial Information
8.4.4. Recent Developments and Future Outlook

8.5. Takara Bio
8.5.1. Company Overview
8.5.2. Service Portfolio
8.5.3. Financial Information
8.5.4. Recent Developments and Future Outlook

8.6. WuXi Biologics
8.6.1. Company Overview
8.6.2. Service Portfolio
8.6.3. Financial Information
8.6.4. Recent Developments and Future Outlook

8.7. Hetero Drugs
8.7.1. Company Overview
8.7.2. Fill / Finish Related Services
8.7.3. Recent Developments and Future Outlook

8.8. Intas Pharmaceuticals
8.8.1. Company Overview
8.8.2. Fill / Finish Related Services
8.8.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Biologics Fill / Finish Service Providers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Scale of Operation
9.3.4. Analysis by Type of Service(s) Offered
9.3.5. Analysis by Type of Process(es)
9.3.6. Analysis by Type of Biologic(s) Involved
9.3.7. Most Active Players: Analysis by Number of Partnerships
9.3.8. Analysis by Geographical Region
9.3.8.1. Intercontinental and Intracontinental Agreements

10. RECENT EXPANSIONS
10.1. Chapter Overview
10.2. Biologics Fill / Finish Service Providers: Recent Expansions
10.2.1. Analysis by Year of Expansion
10.2.2. Analysis by Type of Expansion
10.2.3. Analysis by Type of Packaging Container(s) Used
10.2.4. Analysis by Type of Service(s) Offered
10.2.5. Analysis by Type of Biologic(s) Involved and Scale of Operation
10.2.7. Most Active Players: Analysis by Number of Service(s) Offered
10.2.8. Analysis by Geographical Region
10.2.9. Expansions in North America: Analysis by Type of Service(s) Offered and Type of Biologic(s) Involved
10.2.10. Expansions in Europe: Analysis by Type of Service(s) Offered and Type of Biologic(s) Involved
10.2.11. Expansions in Asia-Pacific: Analysis by Type of Service(s) Offered and Type of Biologic(s) Involved

11. CAPACITY ANALYSIS
11.1. Chapter Overview
11.2. Assumptions and Methodology
11.3. Global Fill / Finish Capacity (by Number of Units Filled)
11.3.1. Analysis by Type of Packaging Container
11.3.2. Analysis by Company Size
11.3.3. Analysis by Scale of Operation
11.3.4. Analysis by Location of Headquarters
11.3.5. Analysis by Location of Fill / Finish Facilities

11.4. Global Fill / Finish Capacity (by Fill Volume)
11.4.1. Analysis by Type of Packaging Container
11.4.2. Analysis by Company Size
11.4.3. Analysis by Scale of Operation
11.4.4. Analysis by Location of Headquarters
11.4.5. Analysis by Location of Fill / Finish Facilities

11.5. Global Fill / Finish Capacity for Ampoules (by Number of Units Filled)
11.5.1 Analysis by Company Size
11.5.2 Analysis by Scale of Operation
11.5.3. Analysis by Location of Headquarters
11.5.4 Analysis by Location of Fill / Finish Facilities

11.6. Global Fill / Finish Capacity for Ampoules (by Fill Volume)
11.6.1. Analysis by Company Size
11.6.2. Analysis by Scale of Operation
11.6.3. Analysis by Location of Headquarters
11.6.4. Analysis by Location of Fill / Finish Facilities

11.7. Global Fill / Finish Capacity for Cartridges (by Number of Units Filled)
11.7.1. Analysis by Company Size
11.7.2. Analysis by Scale of Operation
11.7.3. Analysis by Location of Headquarters
11.7.4. Analysis by Location of Fill / Finish Facilities

11.8. Global Fill / Finish Capacity for Cartridges (by Fill Volume)
11.8.1. Analysis by Company Size
11.8.2. Analysis by Scale of Operation
11.8.3. Analysis by Location of Headquarters
11.8.4. Analysis by Location of Fill / Finish Facilities

11.9. Global Fill / Finish Capacity for Syringes (by Number of Units Filled)
11.9.1 Analysis by Company Size
11.9.2 Analysis by Scale of Operation
11.9.3. Analysis by Location of Headquarters
11.9.4 Analysis by Location of Fill / Finish Facilities

11.10. Global Fill / Finish Capacity for Syringes (by Fill Volume)
11.10.1. Analysis by Company Size
11.10.2. Analysis by Scale of Operation
11.10.3. Analysis by Location of Headquarters
11.10.4. Analysis by Location of Fill / Finish Facilities

11.11. Global Fill / Finish Capacity for Vials (by Number of Units Filled)
11.11.1 Analysis by Company Size
11.11.2 Analysis by Scale of Operation
11.11.3. Analysis by Location of Headquarters
11.11.4. Analysis by Location of Fill / Finish Facilities

11.12. Global Fill / Finish Capacity for Vials (by Fill Volume)
11.12.1. Analysis by Company Size
11.12.2. Analysis by Scale of Operation
11.12.3. Analysis by Location of Headquarters
11.12.4. Analysis by Location of Fill / Finish Facilities

11.13. Conclusion

12. DEMAND ANALYSIS
12.1. Chapter Overview
12.2. Assumptions and Methodology
12.3. Global Demand for Biologics Fill / Finish Services
12.3.1. Analysis by Type of Packaging Container
12.3.2. Analysis by Type of Biologic
12.3.3. Analysis by Therapeutic Area
12.3.4. Analysis by Scale of Operation
12.3.5. Analysis by Company Size
12.3.6. Analysis by Geographical Location

12.4. Demand and Supply Analysis

13. KEY PERFORMANCE INDICATORS FOR BIOLOGIC MANUFACTURING AND FILL / FINISH
13.1. Chapter Overview
13.2. Biologics Manufacturing and Fill / Finish: Key Performance Indicators
13.2.1. Financial Indicators
13.2.1.1. Big Pharma Perspective
13.2.1.2. Contract Manufacturers’ Perspective

13.2.2. Process and Capability-related Indicators
13.2.2.1. Big Pharma Perspective
13.2.2.2. Contract Manufacturers’ Perspective

13.2.3. Market Reputation-related Indicators
13.2.3.1. Big Pharma Perspective
13.2.3.2. Contract Manufacturers’ Perspective

13.2.4. Other Important Performance Indicators
13.3.5. Conclusion

14. REGIONAL CAPABILITY ASSESSMENT
14.1. Chapter Overview
14.2. Assumptions and Key Parameters
14.3. Biologics Fill / Finish Capabilities in North America
14.4. Biologics Fill / Finish Capabilities in Europe
14.5. Biologics Fill / Finish Capabilities in Asia-Pacific and Rest of the World
14.6. Regional analysis of installed biologics fill / finish capacity
14.7. Concluding Remarks

15. MARKET SIZING AND OPPORTUNITY ANALYSIS
15.1. Chapter Overview
15.2. Forecast Methodology
15.3. Overall Biologics Fill / Finish Services Market, 2022-2035
15.3.1. Biologics Fill / Finish Services Market, 2022-2035: Distribution by Type of Packaging Container
15.3.2. Biologics Fill / Finish Services Market, 2022-2035: Distribution by Type of Biologic
15.3.3. Biologics Fill / Finish Services Market, 2022-2035: Distribution by Therapeutic Area
15.3.4. Biologics Fill / Finish Services Market, 2022-2035: Distribution by Scale of Operation
15.3.5. Biologics Fill / Finish Services Market, 2022-2035: Distribution by Company Size
15.3.6. Biologics Fill / Finish Services Market, 2022-2035: Distribution by Geographical Region
15.3.5.1 Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Countries
15.3.5.2. Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Type of Packaging Container
15.3.5.3. Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Type of Biologic
15.3.5.4. Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Therapeutic Area
15.3.5.5. Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Scale of Operation
15.3.5.6. Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Company Size
15.3.5.7. Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Countries
15.3.5.8. Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Type of Packaging Container
15.3.5.9. Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Type of Biologic
15.3.5.10. Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Therapeutic Area
15.3.5.11. Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Scale of Operation
15.3.5.12. Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Company Size
15.3.5.13. Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Countries
15.3.5.14. Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Type of Packaging Container
15.3.5.15. Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Type of Biologic
15.3.5.16. Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Therapeutic Area
15.3.5.17. Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Scale of Operation
15.3.5.18. Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Company Size
15.3.5.19. Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Countries
15.3.5.20. Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Type of Packaging Container
15.3.5.21. Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.3.5.22. Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.3.5.23. Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.3.5.24. Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.3.5.25. Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Countries
15.3.5.26. Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Packaging Container
15.3.5.27. Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.3.5.28. Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.3.5.29. Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.3.5.30. Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Company Size

15.4. Biologics Fill / Finish Services Market for Ampoules, 2022-2035
15.4.1. Biologics Fill / Finish Services Market for Ampoules, 2022-2035: Distribution by Type of Biologic
15.4.2. Biologics Fill / Finish Services Market for Ampoules, 2022-2035: Distribution by Therapeutic Area
15.4.3. Biologics Fill / Finish Services Market for Ampoules, 2022-2035: Distribution by Scale of Operation
15.4.4. Biologics Fill / Finish Services Market for Ampoules, 2022-2035: Distribution by Company Size
15.4.5. Biologics Fill / Finish Services Market for Ampoules, 2022-2035: Distribution by Geographical Region
15.4.4.1. Biologics Fill / Finish Services Market for Ampoules in North America, 2022-2035: Distribution by Type of Biologic
15.4.4.2. Biologics Fill / Finish Services Market for Ampoules in North America, 2022-2035: Distribution by Therapeutic Area
15.4.4.3. Biologics Fill / Finish Services Market for Ampoules in North America, 2022-2035: Distribution by Scale of Operation
15.4.4.4. Biologics Fill / Finish Services Market for Ampoules in North America, 2022-2035: Distribution by Company Size
15.4.4.5. Biologics Fill / Finish Services Market for Ampoules in Europe, 2022-2035: Distribution by Type of Biologic
15.4.4.6. Biologics Fill / Finish Services Market for Ampoules in Europe, 2022-2035: Distribution by Therapeutic Area
15.4.4.7. Biologics Fill / Finish Services Market for Ampoules in Europe, 2022-2035: Distribution by Scale of Operation
15.4.4.8. Biologics Fill / Finish Services Market for Ampoules in Europe, 2022-2035: Distribution by Company Size
15.4.4.9. Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2022-2035: Distribution by Type of Biologic
15.4.4.10. Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2022-2035: Distribution by Therapeutic Area
15.4.4.11. Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2022-2035: Distribution by Scale of Operation
15.4.4.12. Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2022-2035: Distribution by Company Size
15.4.4.13. Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.4.4.14. Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.4.4.15. Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.4.4.16. Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.4.4.17. Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.4.4.18. Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.4.4.19. Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.4.4.20. Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Company Size

15.5. Biologics Fill / Finish Services Market for Cartridges, 2022-2035
15.5.1. Biologics Fill / Finish Services Market for Cartridges, 2022-2035: Distribution by Type of Biologic
15.5.2. Biologics Fill / Finish Services Market for Cartridges, 2022-2035: Distribution by Therapeutic Area
15.5.3. Biologics Fill / Finish Services Market for Cartridges, 2022-2035: Distribution by Scale of Operation
15.5.4. Biologics Fill / Finish Services Market for Cartridges, 2022-2035: Distribution by Company Size
15.5.5. Biologics Fill / Finish Services Market for Cartridges, 2022-2035: Distribution by Geographical Region
15.5.4.1. Biologics Fill / Finish Services Market for Cartridges in North America, 2022-2035: Distribution by Type of Biologic
15.5.4.2. Biologics Fill / Finish Services Market for Cartridges in North America, 2022-2035: Distribution by Therapeutic Area
15.5.4.3. Biologics Fill / Finish Services Market for Cartridges in North America, 2022-2035: Distribution by Scale of Operation
15.5.4.4. Biologics Fill / Finish Services Market for Cartridges in North America, 2022-2035: Distribution by Company Size
15.5.4.5. Biologics Fill / Finish Services Market for Cartridges in Europe, 2022-2035: Distribution by Type of Biologic
15.5.4.6. Biologics Fill / Finish Services Market for Cartridges in Europe, 2022-2035: Distribution by Therapeutic Area
15.5.4.7. Biologics Fill / Finish Services Market for Cartridges in Europe, 2022-2035: Distribution by Scale of Operation
15.5.4.8. Biologics Fill / Finish Services Market for Cartridges in Europe, 2022-2035: Distribution by Company Size
15.5.4.9. Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2022-2035: Distribution by Type of Biologic
15.5.4.10. Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2022-2035: Distribution by Therapeutic Area
15.5.4.11. Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2022-2035: Distribution by Scale of Operation
15.5.4.12. Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2022-2035: Distribution by Company Size
15.5.4.13. Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.5.4.14. Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.5.4.15. Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.5.4.16. Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.5.4.17. Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.5.4.18. Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.5.4.19. Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.5.4.20. Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Company Size

15.6. Biologics Fill / Finish Services Market for Syringes, 2022-2035
15.6.1. Biologics Fill / Finish Services Market for Syringes, 2022-2035: Distribution by Type of Biologic
15.6.2. Biologics Fill / Finish Services Market for Syringes, 2022-2035: Distribution by Therapeutic Area
15.6.3. Biologics Fill / Finish Services Market for Syringes, 2022-2035: Distribution by Scale of Operation
15.6.4. Biologics Fill / Finish Services Market for Syringes, 2022-2035: Distribution by Company Size
15.6.5. Biologics Fill / Finish Services Market for Syringes, 2022-2035: Distribution by Geographical Region
15.6.4.1. Biologics Fill / Finish Services Market for Syringes in North America, 2022-2035: Distribution by Type of Biologic
15.6.4.2. Biologics Fill / Finish Services Market for Syringes in North America, 2022-2035: Distribution by Therapeutic Area
15.6.4.3. Biologics Fill / Finish Services Market for Syringes in North America, 2022-2035: Distribution by Scale of Operation
15.6.4.4. Biologics Fill / Finish Services Market for Syringes in North America, 2022-2035: Distribution by Company Size
15.6.4.5. Biologics Fill / Finish Services Market for Syringes in Europe, 2022-2035: Distribution by Type of Biologic
15.6.4.6. Biologics Fill / Finish Services Market for Syringes in Europe, 2022-2035: Distribution by Therapeutic Area
15.6.4.7. Biologics Fill / Finish Services Market for Syringes in Europe, 2022-2035: Distribution by Scale of Operation
15.6.4.8. Biologics Fill / Finish Services Market for Syringes in Europe, 2022-2035: Distribution by Company Size
15.6.4.9. Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2022-2035: Distribution by Type of Biologic
15.6.4.10. Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2022-2035: Distribution by Therapeutic Area
15.6.4.11. Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2022-2035: Distribution by Scale of Operation
15.6.4.12. Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2022-2035: Distribution by Company Size
15.6.4.13. Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.6.4.14. Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.6.4.15. Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.6.4.16. Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.6.4.17. Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.6.4.18. Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.6.4.19. Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.6.4.20. Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Company Size

15.7. Biologics Fill / Finish Services Market for Vials, 2022-2035
15.7.1. Biologics Fill / Finish Services Market for Vials, 2022-2035: Distribution by Type of Biologic
15.7.2. Biologics Fill / Finish Services Market for Vials, 2022-2035: Distribution by Therapeutic Area
15.7.3. Biologics Fill / Finish Services Market for Vials, 2022-2035: Distribution by Scale of Operation
15.7.4. Biologics Fill / Finish Services Market for Vials, 2022-2035: Distribution by Company Size
15.7.5. Biologics Fill / Finish Services Market for Vials, 2022-2035: Distribution by Geographical Region
15.7.4.1. Biologics Fill / Finish Services Market for Vials in North America, 2022-2035: Distribution by Type of Biologic
15.7.4.2. Biologics Fill / Finish Services Market for Vials in North America, 2022-2035: Distribution by Therapeutic Area
15.7.4.3. Biologics Fill / Finish Services Market for Vials in North America, 2022-2035: Distribution by Scale of Operation
15.7.4.4. Biologics Fill / Finish Services Market for Vials in North America, 2022-2035: Distribution by Company Size
15.7.4.5. Biologics Fill / Finish Services Market for Vials in Europe, 2022-2035: Distribution by Type of Biologic
15.7.4.6. Biologics Fill / Finish Services Market for Vials in Europe, 2022-2035: Distribution by Therapeutic Area
15.7.4.7. Biologics Fill / Finish Services Market for Vials in Europe, 2022-2035: Distribution by Scale of Operation
15.7.4.8. Biologics Fill / Finish Services Market for Vials in Europe, 2022-2035: Distribution by Company Size
15.7.4.9. Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2022-2035: Distribution by Type of Biologic 15.7.4.10. Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2022-2035: Distribution by Therapeutic Area
15.7.4.11. Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2022-2035: Distribution by Scale of Operation
15.7.4.12. Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2022-2035: Distribution by Company Size
15.7.4.13. Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.7.4.14. Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.7.4.15. Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.7.4.16. Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.7.4.17. Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.7.4.18. Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.7.4.19. Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.7.4.20. Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Company Size

16. FUTURE GROWTH OPPORTUNITIES
16.1. Chapter Overview
16.2. Growing Biopharmaceutical Pipeline
16.3. Increase in Outsourcing of Fill / Finish Activities
16.4. Rising Focus on Self-Administration of Drugs
16.5. Advances in Aseptic Fill / Finish Technologies
16.6. Growing Opportunities in the Asia-Pacific Region

17. CASE STUDY: ROBOTIC SYSTEMS IN FILL / FINISH OPERATIONS
17.1. Chapter Overview
17.2. Contract Service Providers: List of Fill / Finish Equipment
17.3. Role of Robotic Systems in Fill / Finish Operations
17.3.1. Types of Robots Used in Pharmaceutical Operations
17.3.2. Key Considerations for Selecting a Robotic System
17.3.3. Advantages of Robotic Systems
17.3.4. Disadvantages of Robotic Systems
17.4. Companies Providing Robots for Use in the Pharmaceutical Industry
17.5. Companies Providing Isolator-based Aseptic Filling Systems
17.6. Concluding Remarks

18. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS FOR ASEPTIC FILL / FINISH
18.1. Chapter Overview
18.2. Role of Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations
18.2.1. Advantages of Ready-to-Use Packaging Components
18.2.2. Disadvantages of Ready-to-Use Packaging Components
18.3. Companies Providing Ready-to-Use Packaging Components
18.4. Conclusion

19. CONCLUDING REMARKS

20. EXECUTIVE INSIGHTS
20.1 Chapter Overview
20.2 IDT Biologika
20.2.1. Company Snapshot
20.2.1. Interview Transcript: Gregor Kawaletz, Chief Commercial Officer

20.3 Cytovance Biologics
20.3.1. Company Snapshot
20.3.2. Interview Transcript: Matt Delaney, Vice President of Business Development and Marketing

20.4. Syngene
20.4.1. Company Snapshot
20.4.2. Interview Transcript: Purushottam Singnurkar, Research Director and Head of Formulation Development

20.5 oncomed manufacturing
20.5.1. Company Snapshot
20.5.2. Interview Transcript: Ales Sima, Business Development Manager

20.6 Yposkesi
20.6.1. Company Snapshot
20.6.2. Interview Transcript: Amit, Technology Watch Manager

20.7 HALIX
20.7.1. Company Snapshot
20.7.2. Interview Transcript: Jos Vergeest, International Business Developer

21. APPENDIX 1: TABULATED DATA

22. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Various Types of Biologics
Figure 3.2 Types of Third-Party Service Providers
Figure 3.3 Commonly Outsourced Operations in the Biopharmaceutical Industry
Figure 3.4 Steps Involved in Fill / Finish of Biologics
Figure 3.5 Key Considerations for Selecting a CMO Partner
Figure 3.6 Risks and Challenges of Outsourcing Biologics Fill / Finish Operations
Figure 4.1 Biologics Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 4.2 Biologics Fill / Finish Service Providers: Distribution by Company Size
Figure 4.3 Biologics Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 4.4 Biologics Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Figure 4.5 Biologics Fill / Finish Service Providers: Distribution by Type of Packaging Container(s) Used
Figure 4.6 Biologics Fill / Finish Service Providers: Distribution by Type of Biologic(s) Manufactured and Type of Packaging Container(s) Used
Figure 4.7 Biologics Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 4.8 Biologics Fill / Finish Service Providers: Distribution by Additional Drug Product-related Services Offered
Figure 5.1 Company Competitiveness Analysis: Biologics Fill / Finish Service Providers in North America
Figure 5.2 Company Competitiveness Analysis: Players Offering Services for Ampoules (North America)
Figure 5.3 Company Competitiveness Analysis: Players Offering Services for Cartridges (North America)
Figure 5.4 Company Competitiveness Analysis: Players Offering Services for Syringes (North America)
Figure 5.5 Company Competitiveness Analysis: Players Offering Services for Vials (North America)
Figure 5.6 Company Competitiveness Analysis: Biologics Fill / Finish Service Providers in (Europe)
Figure 5.7 Company Competitiveness Analysis: Players Offering Services for Ampoules (Europe)
Figure 5.8 Company Competitiveness Analysis: Players Offering Services for Cartridges (Europe)
Figure 5.9 Company Competitiveness Analysis: Players Offering Services for Syringes (Europe)
Figure 5.10 Company Competitiveness Analysis: Players Offering Services for Vials (Europe)
Figure 5.11 Company Competitiveness Analysis: Biologics Fill / Finish Service Providers in (Asia-Pacific and Rest of the World)
Figure 5.12 Company Competitiveness Analysis: Players Offering Services for Ampoules (Asia-Pacific and Rest of the World)
Figure 5.13 Company Competitiveness Analysis: Players Offering Services for Cartridges (Asia-Pacific and Rest of World)
Figure 5.14 Company Competitiveness Analysis: Players Offering Services for Syringes (Asia-Pacific and Rest of the World)
Figure 5.15 Company Competitiveness Analysis: Players Offering Services for Vials (Asia-Pacific and Rest of the World)
Figure 6.1 AbbVie: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 6.2 Baxter International: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 6.3 Merck: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 6.4 Catalent Biologics: Annual Revenues, FY 2017-FY 2022 (USD Billion)
Figure 6.5 Thermo Fisher Scientific: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 6.6 Charles River Laboratories: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 7.1 Boehringer Ingelheim: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 7.2 Lonza: Annual Revenues, 2017-H1 2022 (CHF Billion)
Figure 7.3 Pierre Fabre: Annual Revenues, FY 2018-FY 2021 (EUR Billion)
Figure 7.4 Recipharm: Annual Revenues, FY 2017-FY 2020 (SEK Billion)
Figure 7.6 Wacker Chemie: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 7.7 Fresenius Kabi: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 7.8 Glaxo SmithKline: Annual Revenues, 2017-H1 2022 (GBP Billion)
Figure 8.1 Asymchem: Annual Revenues, 2017-2020 (USD Billion)
Figure 8.2 Samsung Biologics: Annual Revenues, 2017-H1 2022 (KRW Billion)
Figure 8.3 Syngene: Annual Revenues, FY 2017-FY 2022 (INR Million)
Figure 8.4 Takara Bio: Annual Revenues, 2017-H1 2022 (JPY Billion)
Figure 8.5 WuXi Biologics: Annual Revenues, 2017-H1 2022 (RMB Million)
Figure 9.1 Partnerships and Collaborations: Cumulative Trend by Year, 2013-2022
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Scale of Operation
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Service(s) Offered
Figure 9.5 Partnerships and Collaborations: Distribution by Type of Process(es)
Figure 9.6 Partnerships and Collaborations: Distribution by Type of Biologic(s) Involved
Figure 9.7 Most Active Players: Distribution by Number of Partnerships
Figure 9.8 Partnerships and Collaborations: Distribution by Geographical Region
Figure 9.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Expansions: Distribution by Year of Expansion, 2013-2022 (till August)
Figure 10.2 Expansions: Distribution by Type of Expansion
Figure 10.3 Expansions: Distribution by Type of Packaging Container(s) Used
Figure 10.4 Expansions: Distribution by Type of Expansion and Type of Service(s) Offered
Figure 10.5 Expansions: Distribution by Type of Biologic(s) Involved
Figure 10.6 Expansions: Distribution by Type of Biologic(s) Involved and Scale of Operation
Figure 10.7 Expansions: Distribution by Geographical Region
Figure 10.8 Expansions: Distribution by Location of Expansion Project
Figure 10.9 Most Active Players: Distribution by Number of Expansions
Figure 10.10 Expansions in North America: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Figure 10.11 Expansions in Europe: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Figure 10.12 Expansions in Asia-Pacific and Rest of the World: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Figure 11.1 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Type of Packaging (Million Units)
Figure 11.2 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Company Size (Million Units)
Figure 11.3 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Scale of Operation (Million Units)
Figure 11.4 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Headquarters (Million Units)
Figure 11.5 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.6 Global Fill / Finish Capacity (by Fill Volume): Distribution by Type of Packaging (Liters)
Figure 11.7 Global Fill / Finish Capacity (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.8 Global Fill / Finish Capacity (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.9 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.10 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 11.11 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.12 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.13 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.14 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.15 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.16 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.17 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.18 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.19 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.20 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 11.21 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.22 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.23 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.24 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.25 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.26 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.27 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.28 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.29 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.30 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 11.31 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.32 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.33 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.34 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.35 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.36 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.37 Global Fill / Finish Capacity for Syringes (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.38 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.39 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.40 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 11.41 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.42 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.43 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.44 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.45 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.46 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.47 Global Fill / Finish Capacity for Vials (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.48 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.49 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.50 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 12.1 Global Demand for Biologics Fill / Finish Services (Million Liters)
Figure 12.2 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Packaging Container (Liters)
Figure 12.3 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Biologic (Liters)
Figure 12.4 Global Demand for Biologics Fill / Finish Services: Distribution by Therapeutic Area (Liters)
Figure 12.5 Global Demand for Biologics Fill / Finish Services: Distribution by Scale of Operation (Liters)
Figure 12.6 Global Demand for Biologics Fill / Finish Services: Distribution by Company Size (Liters)
Figure 12.7 Global Demand for Biologics Fill / Finish Services: Distribution by Geographical Location (Liters)
Figure 12.8 Global Biologics Fill / Finish Services: Demand and Supply, 2022-2035
Figure 13.1 Biologics Manufacturing and Fill / Finish: Key Performance Indicators (KPIs)
Figure 13.2 Financial Indicators: Comparative Analysis of KPIs Considered by Big Pharma Companies
Figure 13.3 Financial Indicators: Big Pharma Perspective
Figure 13.4 Financial Indicators: Contract Manufacturers’ Perspective
Figure 13.5 Process / Capability-related Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.6 Process / Capability-related Indicators: Big Pharma Perspective
Figure 13.7 Process / Capability-related Indicators: Contract Manufacturers’ Perspective
Figure 13.8 Market Reputation-related Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.9 Market Reputation-related Indicators: Big Pharma Perspective
Figure 13.10 Market Reputation-related Indicators: Contract Manufacturers’ Perspective
Figure 13.11 Other Performance Indicators: Contract Manufacturers’ Perspective
Figure 14.1 Regional Capability Assessment: Biologic Fill / Finish Capabilities in North America
Figure 14.2 Regional Capability Assessment: Biologic Fill / Finish Capabilities in Europe
Figure 14.3 Regional Capability Assessment: Biologic Fill / Finish Capabilities in Asia-Pacific and Rest of the World
Figure 14.4 Regional Capability Analysis: Biologic Fill / Finish Installed Capacity in Different Geographical Regions
Figure 14.4 Regional Capability Assessment: Comparison of Capabilities across Different Regions
Figure 15.1 Overall Biologics Fill / Finish Services Market, 2022-2035 (USD Billion)
Figure 15.2 Biologics Fill / Finish Services Market, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.3 Biologics Fill / Finish Services Market, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.4 Biologics Fill / Finish Services Market, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.5 Biologics Fill / Finish Services Market, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.6 Biologics Fill / Finish Services Market, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.7 Biologics Fill / Finish Services Market, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.8 Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Countries (USD Million)
Figure 15.9 Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 1510 Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.11 Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.12 Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.13 Biologics Fill / Finish Services Market in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.14 Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Countries (USD Million)
Figure 15.15 Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.16 Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.17 Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Therapeutic Are (USD Million)
Figure 15.18 Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.19 Biologics Fill / Finish Services Market in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.20 Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Countries (USD Million)
Figure 15.21 Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.22 Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.23 Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.24 Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.25 Biologics Fill / Finish Services Market in Asia-Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.26 Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Countries (USD Million)
Figure 15.27 Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.28 Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.29 Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.30 Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.31 Biologics Fill / Finish Services Market in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.32 Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Countries (USD Million)
Figure 15.33 Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.34 Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.35 Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.36 Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.37 Biologics Fill / Finish Services Market in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.38 Biologics Fill / Finish Services Market for Ampoules, 2022-2035 (USD Million)
Figure 15.39 Biologics Fill / Finish Services Market for Ampoules, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.40 Biologics Fill / Finish Services Market for Ampoules, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.41 Biologics Fill / Finish Services Market for Ampoules, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.42 Biologics Fill / Finish Services Market for Ampoules, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.43 Biologics Fill / Finish Services Market for Ampoules, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.44 Biologics Fill / Finish Services Market for Ampoules in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.45 Biologics Fill / Finish Services Market for Ampoules in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.46 Biologics Fill / Finish Services Market for Ampoules in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.47 Biologics Fill / Finish Services Market for Ampoules in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.48 Biologics Fill / Finish Services Market for Ampoules in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.49 Biologics Fill / Finish Services Market for Ampoules in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.50 Biologics Fill / Finish Services Market for Ampoules in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.51 Biologics Fill / Finish Services Market for Ampoules in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.52 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.53 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.54 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.55 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.56 Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.57 Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.58 Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.59 Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.60 Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.61 Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.62 Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.63 Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.64 Biologics Fill / Finish Services Market for Cartridges, 2022-2035(USD Million)
Figure 15.65 Biologics Fill / Finish Services Market for Cartridges, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.66 Biologics Fill / Finish Services Market for Cartridges, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.67 Biologics Fill / Finish Services Market for Cartridges, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.68 Biologics Fill / Finish Services Market for Cartridges, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.69 Biologics Fill / Finish Services Market for Cartridges, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.70 Biologics Fill / Finish Services Market for Cartridges in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.71 Biologics Fill / Finish Services Market for Cartridges in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.72 Biologics Fill / Finish Services Market for Cartridges in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.73 Biologics Fill / Finish Services Market for Cartridges in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.74 Biologics Fill / Finish Services Market for Cartridges in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.75 Biologics Fill / Finish Services Market for Cartridges in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.76 Biologics Fill / Finish Services Market for Cartridges in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.77 Biologics Fill / Finish Services Market for Cartridges in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.78 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.79 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.80 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.81 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.82 Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.83 Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.84 Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.85 Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.86 Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.87 Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.88 Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.89 Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.90 Biologics Fill / Finish Services Market for Syringes, 2022-2035 (USD Million)
Figure 15.91 Biologics Fill / Finish Services Market for Syringes, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.92 Biologics Fill / Finish Services Market for Syringes, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.93 Biologics Fill / Finish Services Market for Syringes, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.94 Biologics Fill / Finish Services Market for Syringes, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.95 Biologics Fill / Finish Services Market for Syringes, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.96 Biologics Fill / Finish Services Market for Syringes in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.97 Biologics Fill / Finish Services Market for Syringes in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.98 Biologics Fill / Finish Services Market for Syringes in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.99 Biologics Fill / Finish Services Market for Syringes in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.100 Biologics Fill / Finish Services Market for Syringes in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.101 Biologics Fill / Finish Services Market for Syringes in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.102 Biologics Fill / Finish Services Market for Syringes in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.103 Biologics Fill / Finish Services Market for Syringes in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.104 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.105 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.106 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.107 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.108 Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.109 Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.110 Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.111 Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.112 Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.113 Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.114 Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.115 Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.116 Biologics Fill / Finish Services Market for Vials, 2022-2035(USD Million)
Figure 15.117 Biologics Fill / Finish Services Market for Vials, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.118 Biologics Fill / Finish Services Market for Vials, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.119 Biologics Fill / Finish Services Market for Vials, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.120 Biologics Fill / Finish Services Market for Vials, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.121 Biologics Fill / Finish Services Market for Vials, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.122 Biologics Fill / Finish Services Market for Vials in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.123 Biologics Fill / Finish Services Market for Vials in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.124 Biologics Fill / Finish Services Market for Vials in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.125 Biologics Fill / Finish Services Market for Vials in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.126 Biologics Fill / Finish Services Market for Vials in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.127 Biologics Fill / Finish Services Market for Vials in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.128 Biologics Fill / Finish Services Market for Vials in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.129 Biologics Fill / Finish Services Market for Vials in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.130 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.131 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.132 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.133 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.134 Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.135 Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.136 Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.137 Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.138 Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.139 Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.140 Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.141 Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 16.1 Growth Opportunities for Biologics Fill / Finish Service Providers
Figure 16.2 Drug Products Approved by the FDA, 2011-2021
Figure 17.1 Key Considerations for Selecting a Robotic System
Figure 17.2 Advantages of Robotic Systems in Pharmaceutical Operations
Figure 18.1 Key Drivers of Ready-to-Use Platform
Figure 19.1 Concluding Remarks: Current Biologic Fill / Finish Service Providers Market Landscape Summary
Figure 19.2 Concluding Remarks: Recent Partnerships
Figure 19.3 Concluding Remarks: Recent Expansions
Figure 19.4 Concluding Remarks: Capacity Analysis
Figure 19.5 Concluding Remarks: Demand Analysis
Figure 19.6 Concluding Remarks: Market Sizing and Opportunity Analysis for Biologic Fill / Finish Services Market

List Of Tables

Table 3.1 Best-Selling Drugs of 2022
Table 4.1 Biologics Fill / Finish Service Providers: List of Companies
Table 4.2 Biologics Fill / Finish Service Providers: Information on Type of Packaging Container(s) Used
Table 4.3 Biologics Fill / Finish Service Providers: Information on Type of Biologic(s) Manufactured
Table 4.4 Biologics Fill / Finish Service Providers: Information on Scale of Operation
Table 4.5 Biologics Fill / Finish Service Providers: Information on Additional Drug Product-related Services Offered
Table 4.6 Biologics Fill / Finish Service Providers: Information on Fill / Finish Capacity
Table 6.1 Biologics Fill / Finish Service Providers in North America: List of Profiled Companies
Table 6.2 AbbVie Contract Manufacturing: Company Overview
Table 6.3 AbbVie Contract Manufacturing: Overview of Service Portfolio
Table 6.4 AbbVie Contract Manufacturing: Overview of Fill / Finish Services
Table 6.5 AbbVie Contract Manufacturing: Sterile Manufacturing Facilities
Table 6.6 AbbVie Contract Manufacturing: Recent Developments and Future Outlook
Table 6.7 BioPharma Solutions: Company Overview
Table 6.8 BioPharma Solutions: Overview of Service Portfolio
Table 6.9 BioPharma Solutions: Overview of Fill / Finish Services
Table 6.8 BioPharma Solutions: Sterile Manufacturing Facilities
Table 6.10 BioPharma Solutions: Recent Developments and Future Outlook
Table 6.11 BioReliance: Company Overview
Table 6.12 BioReliance: Overview of Service Portfolio
Table 6.13 BioReliance: Overview of Fill / Finish Services
Table 6.14 BioReliance: Sterile Manufacturing Facilities
Table 6.15 BioReliance: Recent Developments and Future Outlook
Table 6.16 Catalent Biologics: Company Overview
Table 6.17 Catalent Biologics: Overview of Service Portfolio
Table 6.18 Catalent Biologics: Overview of Fill / Finish Services
Table 6.19 Catalent Biologics: Sterile Manufacturing Facilities
Table 6.20 Catalent Biologics: Recent Developments and Future Outlook
Table 6.21 Patheon: Company Overview
Table 6.22 Patheon: Overview of Service Portfolio
Table 6.23 Patheon: Overview of Fill / Finish Services
Table 6.24 Patheon: Sterile Manufacturing Facilities
Table 6.25 Patheon: Recent Developments and Future Outlook
Table 6.26 Charles River Laboratories: Company Snapshot
Table 6.27 Charles River Laboratories: Overview of Fill / Finish Services
Table 6.28 Charles River Laboratories: Recent Developments and Future Outlook
Table 7.1 Biologics Fill / Finish Service Providers in Europe: List of Profiled Companies
Table 7.2 Boehringer Ingelheim BioXcellence: Company Overview
Table 7.3 Boehringer Ingelheim BioXcellence: Overview of Service Portfolio
Table 7.4 Boehringer Ingelheim BioXcellence: Overview of Fill / Finish Services
Table 7.5 Boehringer Ingelheim BioXcellence: Sterile Manufacturing Facilities
Table 7.6 Boehringer Ingelheim BioXcellence: Recent Developments and Future Outlook
Table 7.7 Lonza: Company Overview
Table 7.8 Lonza: Overview of Service Portfolio
Table 7.9 Lonza: Overview of Fill / Finish Services
Table 7.10 Lonza: Sterile Manufacturing Facilities
Table 7.11 Lonza: Recent Developments and Future Outlook
Table 7.12 Pierre Fabre: Company Overview
Table 7.13 Pierre Fabre: Overview of Service Portfolio
Table 7.14 Pierre Fabre: Overview of Fill / Finish Services
Table 7.15 Pierre Fabre: Sterile Manufacturing Facilities
Table 7.16 Pierre Fabre: Recent Developments and Future Outlook
Table 7.17 Recipharm: Company Overview
Table 7.18 Recipharm: Overview of Service Portfolio
Table 7.19 Recipharm: Overview of Fill / Finish Services
Table 7.20 Recipharm: Sterile Manufacturing Facilities
Table 7.21 Recipharm: Recent Developments and Future Outlook
Table 7.22 Wacker Biotech: Company Overview
Table 7.23 Wacker Biotech: Overview of Service Portfolio
Table 7.24 Wacker Biotech: Overview of Fill / Finish Related Services
Table 7.25 Wacker Biotech: Sterile Manufacturing Facilities
Table 7.26 Wacker Biotech: Recent Developments and Future Outlook
Table 7.27 Fareva: Company Overview
Table 7.28 Fareva: Overview of Fill / Finish Services
Table 7.29 Fareva: Recent Developments and Future Outlook
Table 7.30 Fresenius Kabi: Company Overview
Table 7.31 Fresenius Kabi: Overview of Fill / Finish Services
Table 7.32 Glaxo SmithKline: Company Overview
Table 7.33 Glaxo SmithKline: Overview of Fill / Finish Services
Table 7.34 Glaxo SmithKline: Recent Developments and Future Outlook
Table 8.1 Biologics Fill / Finish Service Providers in Asia-Pacific: List of Profiled Companies
Table 8.2 Asymchem: Company Overview
Table 8.3 Asymchem: Overview of Service Portfolio
Table 8.4 Asymchem: Overview of Fill / Finish Services
Table 8.5 Asymchem: Sterile Manufacturing Facilities
Table 8.6 Asymchem: Recent Developments and Future Outlook
Table 8.7 Samsung Biologics: Company Overview
Table 8.8 Samsung Biologics: Overview of Service Portfolio
Table 8.9 Samsung Biologics: Overview of Fill / Finish Services
Table 8.10 Samsung Biologics: Recent Developments and Future Outlook
Table 8.11 Syngene: Company Overview
Table 8.12 Syngene: Overview of Service Portfolio
Table 8.13 Syngene: Overview of Fill / Finish Services
Table 8.14 Syngene: Recent Developments and Future Outlook
Table 8.15 Takara Bio: Company Overview
Table 8.16 Takara Bio: Overview of Service Portfolio
Table 8.17 Takara Bio: Overview of Fill / Finish Services
Table 8.18 Takara Bio: Recent Developments and Future Outlook
Table 8.19 WuXi Biologics: Company Overview
Table 8.20 WuXi Biologics: Overview of Services Portfolio
Table 8.21 Wuxi Biologics: Overview of Fill / Finish Services
Table 8.22 WuXi Biologics: Sterile Manufacturing Facilities
Table 8.23 WuXi Biologics: Recent Developments and Future Outlook
Table 8.24 Hetero Drugs: Company Overview
Table 8.25 Hetero Drugs: Overview of Fill / Finish Services
Table 8.26 Intas Pharmaceuticals: Company Overview
Table 8.27 Intas Pharmaceuticals: Overview of Fill / Finish Services
Table 9.1 Biologics Fill / Finish Service Providers: Partnerships and Collaborations, 2013-2022
Table 9.2 Partnerships and Collaborations: Information on Type of Service(s) Offered, 2013-2022
Table 9.3 Partnerships and Collaborations: Information on Type of Biologic(s) Involved, 2013-2022
Table 10.1 Biologics Fill / Finish Service Providers: Recent Expansions, 2013-2022
Table 10.2 Expansions, 2013-2022: Information on Type of Packaging Container(s) Used
Table 10.3 Recent Expansions, 2013-2022: Information on Type of Service(s) Offered
Table 10.4 Expansions, 2013-2022: Information on Type of Biologic(s) Involved
Table 11.1 Average Fill / Finish Capacity for Ampoules (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.2 Average Fill / Finish Capacity for Cartridges (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.3 Average Fill / Finish Capacity for Syringes (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.4 Average Fill / Finish Capacity for Vials (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.5 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size
Table 11.6 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size
Table 11.7 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size
Table 11.8 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size
Table 11.9 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Company Size
Table 11.10 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size
Table 11.11 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size
Table 11.12 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Company Size
Table 12.1 Biologics Fill / Finish Outsourcing: Annual Supply, 2022-2035 (Million Liters)
Table 16.1 Patent Expiry of Biologics, 2021-2023
Table 17.1 Biologics Fill / Finish Service Providers: Information on Fill / Finish Equipment
Table 17.2 List of Pharmaceutical Robotics Manufacturers
Table 17.3 Isolator based Aseptic Filling Systems: Information on Compatible Primary Container
Table 18.1 List of Companies Supplying Ready-to-Use Packaging Components
Table 19.1 Biologics Fill / Finish Service Providers: Summary of the Report
Table 21.1 Biologics Fill / Finish Service Providers: Distribution by Year of Establishment
Table 21.2 Biologics Fill / Finish Service Providers: Distribution by Company Size
Table 21.3 Biologics Fill / Finish Service Providers: Distribution by Location of Headquarters
Table 21.4 Biologics Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Table 21.5 Biologics Fill / Finish Service Providers: Distribution by Type of Packaging Container(s) Used
Table 21.6 Biologics Fill / Finish Service Providers: Distribution by Type of Biologic(s) Manufactured and Type of Packaging Container(s) Used
Table 21.7 Biologics Fill / Finish Service Providers: Distribution by Scale of Operation
Table 21.8 Biologics Fill / Finish Service Providers: Distribution by Type of Additional Drug Product-related Services Offered
Table 21.9 AbbVie: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.10 Baxter International: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.11 Merck: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.12 Catalent Biologics: Annual Revenues, FY 2017-FY 2022 (USD Billion)
Table 21.13 Thermo Fisher Scientific: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.14 Charles River Laboratories: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.15 Boehringer Ingelheim: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.16 Lonza: Annual Revenues, 2017-H1 2022 (CHF Billion)
Table 21.17 Pierre Fabre: Annual Revenues, FY 2018-FY 2021 (EUR Billion)
Table 21.18 Recipharm: Annual Revenues, FY 2017-FY 2020 (SEK Billion)
Table 21.19 Wacker Chemie: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.20 Fresenius Kabi: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.21 Glaxo SmithKline: Annual Revenues, 2017-H1 2022 (GBP Billion)
Table 21.22 Asymchem: Annual Revenues, FY 2017-FY 2020 (USD Billion)
Table 21.23 Samsung Biologics: Annual Revenues, 2017-H1 2022 (KRW Billion)
Table 21.24 Syngene: Annual Revenues, 2017-2022 (INR Million)
Table 21.25 Takara Bio: Annual Revenues, 2017-H1 2022 (JPY Billion)
Table 21.26 WuXi Biologics: Annual Revenues, 2017-H1 2022 (RMB Million)
Table 21.27 Partnerships and Collaborations: Cumulative Year-wise Trend, 2013-2022
Table 21.28 Partnerships and Collaborations: Distribution by Type of Partnership
Table 21.29 Partnerships and Collaborations: Distribution by Scale of Operation
Table 21.30 Partnerships and Collaborations: Distribution by Type of Service(s) Offered
Table 21.31 Partnerships and Collaborations: Distribution by Type of Process(es)
Table 21.32 Partnerships and Collaborations: Distribution by Types of Biologic(s) Involved
Table 21.33 Most Active Players: Distribution by Number of Partnerships
Table 21.34 Partnerships and Collaborations: Distribution by Geographical Region
Table 21.35 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 21.36 Expansions: Distribution by Year of Expansion, 2013-2022
Table 21.37 Expansions: Distribution by Type of Expansion
Table 21.38 Expansions: Distribution by Type of Packaging Container(s) Used
Table 21.39 Expansions: Distribution by Type of Expansion and Type of Service(s) Offered
Table 21.40 Expansions: Distribution by Type of Biologic(s) Involved
Table 21.41 Expansions: Distribution by Type of Biologic and Scale of Operation
Table 21.42 Expansions: Distribution by Geographical Location
Table 21.43 Expansions: Distribution by Location of Expansion Project
Table 21.44 Most Active Players: Distribution by Number of Expansions
Table 21.45 Expansions in North America: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Table 21.46 Expansions in Europe: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Table 21.47 Expansions in Asia-Pacific: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Table 21.48 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Type of Packaging (Million Units)
Table 21.49 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Company Size (Million Units)
Table 21.50 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Scale of Operation (Million Units)
Table 21.51 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Headquarters (Million Units)
Table 21.52 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.53 Global Fill / Finish Capacity (by Fill Volume): Distribution by Type of Packaging (Kilo Liters)
Table 21.54 Global Fill / Finish Capacity (by Fill Volume): Distribution by Company Size (Kilo Liters)
Table 21.55 Global Fill / Finish Capacity (by Fill Volume): Distribution by Scale of Operation (Kilo Liters)
Table 21.56 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Headquarters (Kilo Liters)
Table 21.57 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Kilo Liters)
Table 21.58 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.59 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.60 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.61 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.62 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size (Liters)
Table 21.63 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.64 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.65 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution byLocation of Fill / Finish Facilities (Liters)
Table 21.66 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.67 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.68 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.69 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.70 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size (Liters)
Table 21.71 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.72 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.73 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Table 21.74 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Company Size
Table 21.75 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.76 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.77 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.78 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size (Liters)
Table 21.79 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.80 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.81 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Table 21.82 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.83 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.84 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.85 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.86 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Company Size (Liters)
Table 21.87 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.88 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.89 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Table 21.90 Global Demand for Biologics Fill / Finish Services (Million Liters)
Table 21.91 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Packaging Container (Kilo Liters)
Table 21.92 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Biologic (Kilo Liters)
Table 21.93 Global Demand for Biologics Fill / Finish Services: Distribution by Therapeutic Area (Kilo Liters)
Table 21.94 Global Demand for Biologics Fill / Finish Services: Distribution by Scale of Operation (Kilo Liters)
Table 21.95 Global Demand for Biologics Fill / Finish Services: Distribution by Company Size (Kilo Liters)
Table 21.96 Global Demand for Biologics Fill / Finish Services: Distribution by Geographical Location (Kilo Liters)
Table 21.97 Global Biologics Fill / Finish Services: Demand and Supply, 2022-2035
Table 21.98 Overall Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Billion)
Table 21.99 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.100 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.101 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.102 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.103 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.104 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.105 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.106 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.107 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.108 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.109 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.110 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.111 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.112 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.113 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.114 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.115 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.116 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.117 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.118 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.119 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.120 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.121 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.122 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.123 Biologics Fill / Finish Services Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.124 Biologics Fill / Finish Services Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.125 Biologics Fill / Finish Services Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.126 Biologics Fill / Finish Services Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.127 Biologics Fill / Finish Services Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.128 Biologics Fill / Finish Services Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.129 Biologics Fill / Finish Services Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.130 Biologics Fill / Finish Services Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.131 Biologics Fill / Finish Services Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.132 Biologics Fill / Finish Services Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.133 Biologics Fill / Finish Services Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.134 Biologics Fill / Finish Services Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.135 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.136 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.137 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.138 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.139 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.140 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.141 Biologics Fill / Finish Services Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.142 Biologics Fill / Finish Services Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.143 Biologics Fill / Finish Services Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale pf Operation (USD Million)
Table 21.144 Biologics Fill / Finish Services Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.145 Biologics Fill / Finish Services Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.146 Biologics Fill / Finish Services Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.147 Biologics Fill / Finish Services Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.148 Biologics Fill / Finish Services Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.149 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.150 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.151 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.152 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.153 Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.154 Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.155 Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.156 Biologics Fill / Finish Services Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.157 Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.158 Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.159 Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.160 Biologics Fill / Finish Services Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.161 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.162 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.163 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.164 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.165 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.166 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.167 Biologics Fill / Finish Services Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.168 Biologics Fill / Finish Services Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.169 Biologics Fill / Finish Services Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.170 Biologics Fill / Finish Services Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.171 Biologics Fill / Finish Services Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.172 Biologics Fill / Finish Services Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.173 Biologics Fill / Finish Services Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.174 Biologics Fill / Finish Services Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.175 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.176 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.177 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.178 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.179 Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.180 Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.181 Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.182 Biologics Fill / Finish Services Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.183 Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.184 Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.185 Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.186 Biologics Fill / Finish Services Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.187 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.188 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.189 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.190 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.191 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.192 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.193 Biologics Fill / Finish Services Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.194 Biologics Fill / Finish Services Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.195 Biologics Fill / Finish Services Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.196 Biologics Fill / Finish Services Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.197 Biologics Fill / Finish Services Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.198 Biologics Fill / Finish Services Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.199 Biologics Fill / Finish Services Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.200 Biologics Fill / Finish Services Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.201 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.202 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.203 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.204 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.205 Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.206 Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.207 Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.208 Biologics Fill / Finish Services Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.209 Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.210 Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.211 Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.212 Biologics Fill / Finish Services Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.213 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.214 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.215 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.216 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.217 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.218 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.219 Biologics Fill / Finish Services Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.220 Biologics Fill / Finish Services Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.221 Biologics Fill / Finish Services Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.222 Biologics Fill / Finish Services Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.223 Biologics Fill / Finish Services Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.224 Biologics Fill / Finish Services Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.225 Biologics Fill / Finish Services Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.226 Biologics Fill / Finish Services Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.227 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.228 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.229 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.230 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.231 Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.232 Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.233 Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.234 Biologics Fill / Finish Services Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.235 Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.236 Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.237 Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.238 Biologics Fill / Finish Services Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.239 Drug Product Pipeline Approved by the FDA, 2011-2021

List Of Companies

The following companies and organizations have been mentioned in the report:

3P Biopharmaceuticals
Aalto Scientific
ABB
AbbVie
AbbVie Contract Manufacturing
AbTis
Abzena
ACG
ACIC Pharmaceutical Machinery
AdaptVac
ADC Biotechnology
Adimmune
Advanced BioScience Laboratories
Aenova
Affinity Life Sciences
Afton Scientific
Agilis Biotherapeutics
AJ Biologics
Ajinomoto Bio-Pharma Services
Akron Biotech
AKSO
Akums Drugs and Pharmaceuticals
Alanza
Alcami
Alcon
Aldevron
Alkermes
Althea
Amatsigroup
Ambica Pharma Machines
Amgen
Amicus Therapeutics
AMRI
Anchiano Therapeutics (formerly known as BioCanCell)
Anchor Mark
Anthos Therapeutics
apceth Biopharma
APG Europe
Aptar Pharma
Aptuit
Arabio
ARaymond Life
Arch Biopartners
Argonaut Manufacturing Services
ARISTO
Ascendia Pharmaceuticals
Aseptic Technologies
Asklepios BioPharmaceutical
AST
AstraZeneca
Asymchem
Ausia BioTech
Austrianova
Automated Systems of Tacoma
Avid Bioservices
Avrio Biopharmaceuticals
AWS Bio-Pharma Technologies
Axcellerate Pharma
B. Braun’s OEM Division
Baccinex
Bausch & Ströbel
BAUSCH Advanced Technology Group (BATG)
Baxter BioPharma Solutions
Bayer
Berkshire Sterile Manufacturing
Binex
Bio Elpida
Bio-Concept Laboratories
BioConnection
Biofabri
Biogen
BioMARC
Biomay
Biomedical Advanced Research and Development Authority (BARDA)
BioNTech
BioPharma Solutions
BioReliance
BioSkryb
BioTechLogic
BioTechniques
Biovian
BirgiMefar
Boehringer Ingelheim BioXcellence
Bolt Biotherapeutics
Boston Children’s Hospital
Bristol-Myers Squibb
Bryllan
BSP Pharmaceuticals
Burrard Pharmaceuticals
Bushu Pharmaceuticals
Cangene Corporation
Canton Biologics
CARBOGEN AMCIS
Catalent Biologics
Celgene
Cell Culture Company
Cellin Technologies
Celonic
Celsee
Cenexi
Cerbios-Pharma
Cerium Pharmaceuticals
ChemPartner
Chime Biologics
China Gateway Biologics
CinnaGen
Citryll
CMAB Biopharma
CMC Biologics
CMIC CMO
Coalition for the Promotion of Innovations for Epidemic Preparedness (CEPI)
Cobra Biologics
Cognate BioServices
Cognitus Consulting
Coldstream Laboratories
Colorado State University
Columbus Venture Partners
Comecer
Cook Pharmica
CordenPharma
Creative Biolabs
Crystal Pharma
CureVac
CytoDyn
Cytovance Biologics
Daikyo Seiko
Dalton Pharma Services
Dara Pharma
Datwyler Sealing Solutions
DENSO
Dhruv Life Sciences
Disposable Lab
DM Bio
Drugs for Neglected Disease Initiative (DNDi)
DSM Pharmaceutical Products
DWK Life Sciences
EirGen Pharma
EirGenix
Eli Lilly
EMA Pharmaceuticals
Emcure Pharmaceuticals
Emergent BioSolutions
Esco Aster
Etinpro
EuBiologics
EUCODIS Bioscience
Eurofins BioPharma Product Testing Netherlands
Eurofins Scientific
EVER Pharma
ExCellThera
Exelead
Experic
Extract Technology
FANUC America
Fareva
FinVector
Formosa Laboratories
Fresenius Kabi Contract Manufacturing
Früh Verpackungstechnik
FUJIFILM Diosynth Biotechnologies
GC Pharma
GEA
Genentech
GeneQuantum Healthcare
Generic Specialities
GenIbet Biopharmaceuticals
Genovior Biotech
Genprex
Gerresheimer
Getinge
GigaGen
Gilead
GlaxoSmithKline
GLyPharma
Goodwin Biotechnology
GP Pharm
Grand River Aseptic Manufacturing
Groninger
GTCR
Gulf Biotech
HALIX
Hameln Pharma
Handl Therapeutics
Hansa Biopharma
Hapten Sciences
Health Biotech
Healthcare Pharmaceuticals
Hepalink
Hetero Drugs
Hisun Pharmaceuticals USA
Hookipa Pharma
Hospira One 2 One
Humanigen
Hybio Pharmaceutical
Hycult Biotech
iBio
IDT Biologika
IMA Group
Immune Pharmaceuticals
Immunex
Infectious Disease Research Institute
Injectalia
Intas Pharmaceuticals
Integrity Bio
Irvine Pharmaceutical Services
Istituto Biochimico Italiano Giovanni Lorenzini
Janssen Pharmaceuticals
JHL Biotech
Jiangsu Yaohai Bio-pharmaceutical
Johnson & Johnson
JOINN Biologics
Jubilant HollisterStier
Kanda BioTech
Kaneka Eurogentec
Kawasaki Heavy Industries
Kaysersberg Pharmaceuticals
Kemwell Biopharma
Klenzaids
Kohlberg and Mubadala
KUKA
Kymanox
Laboratorios Farmaceuticos ROVI
Laekna Therapeutics
LakePharma
LamKap Bio
Lava Therapeutics
Liof Pharma
Lonza
LSNE Contract Manufacturing
Lubrizol
LuinaBio
LyoGen
Lyophilization Services of New England (LSNE)
Lyophilization Technology
M&O Perry Industries
MabPlex
Madison Dearborn Partners
Marchesini Group
MassBiologics
Massman Automation Designs
MaSTherCell
Masy BioServices
MEDInstill
Merck
Microdermics
Millmount Healthcare (acquired by PCI Pharma Services)
Miltenyi Biotec
Minaris Regenerative Medicine
Mitsubishi Electric
Moderna
Morgridge Institute for Research (MIR)
Mycenax Biotech
Najít Technologies
National Health Research Institutes (NHRI)
National Institutes of Health
NBE-Therapeutics
Neuma
Nikon CeLL innovation
Ningbo Zhengli Pharmaceutical Packing
Nipro PharmaPackaging
Nitto Avecia Pharma Services
Nitto Denko Avecia
n-Lorem Foundation
Northway Biotechpharma
Nova Laboratories
Novartis
Novasep
Novavax
Noveome Biotherapeutics
Novex Innovations
Novo Nordisk
Nykode (formerly known as Vaccibody)
Ology Bioservices
OmniChem
Ompi
OMRON Industrial Automation
oncomed manufacturing
Oncotec Pharma Produktion
OPKO Health
OPTIMA
Ori Biotech
Oryn Therapeutics
OSO Biopharmaceuticals Manufacturing (acquired by AMRI)
Ottawa Hospital Research Institute
Oxford BioMedica
Pace Analytical Services
PaizaBio
Pall Life Sciences
Panacea Pharmaceuticals
Paragon Bioservices
Particle Measuring Systems (PMS)
Partners Group
Patheon
PCI Pharma Services
Penn Pharmaceutical Services
Permira
Pfizer
Pfizer CentreOne
Pharmaceutical Packaging Professionals
Pharmaceutics International
PharmaTher
Pierre Fabre
Piramal Pharma Solutions
Polpharma Biologics
Polymun Scientific
Praxis Pharmaceutical
PrimaPharma
Prince Sterilization Services
PSC Biotech
PYRAMID Laboratories
Quality BioResources
QureBio
Recipharm
Regeneron Pharmaceuticals
Reliance Life Sciences
Rentschler Biopharma
Rentschler Fill Solutions
Resilience
Revance Therapeutics
Roche
Romaco
Rommelag CMO
RoslinCT
ROTA
Ruibo Bio-Technology
Russian Direct Investment Fund (RDIF)
Saint-Gobain
Sam Chun Dang Pharm
Samsung Bioepis
Samsung Biologics
Sandoz
Sanofi
Saudi Biotechnology Manufacturing
Schematic Engineering Industries
SCHOTT
ScinoPharm
Seiko Epson
Selecta Biosciences
Sensorion
Shanghai BravoBio
Sharp
Shengnuo Peptide
Shenzhen Techdow Pharmaceutical
Sherpa Clinical Packaging (acquired by PCI Pharma Services)
Shibuya
Shree Bhagwati Machtech
SialoCarb
Siam Bioscience
Siegfried Holding
Singota Solutions
Sio Gene Therapies
SiO2 Medical Products
SIRION Biotech
Sirton Pharmaceuticals
SKAN
Snowbell Machines
SP
Spanish Agency of Medicines and Medical Devices (AEMPS)
Square Pharmaceuticals
Staubli
Stelis Biopharma
Steriline
Surrozen
Swissfillon
Symbiosis Pharmaceutical
Symphogen
SynCo Bio Partners
Syngene
Synklino
Syntegon
Sypharma
TAIYO Pharma
Takara Bio
Tanvex BioPharma
Taysha Gene Therapies
Tekpak
ten23 health
The Carlyle Group
Themis
Therapure Biomanufacturing
Theratechnologies
Thermo Fisher Scientific
Tofflon
Transcoject
TransMedics
TriPharm Services (acquired by Alcami)
TRUKING
Tubulis
U.S. Army Contracting Command
UCB
Ultragenyx Pharmaceutical
Universal Robots
University of Queensland
USV
Vaccine and Infectious Disease Organization (VIDO)
Vanrx
Vaxine
VBI Vaccines
Vetter Pharma
VGXI
Vibalogics
Vigene Biosciences
Viralgen
VxP Biologics
WACKER Biotech
Waisman Biomanufacturing
Watson-Marlow Fund
West Pharmaceutical Services
WuXi Biologics
Wuxi Fortune Pharmaceutical
Wuxi Griffin
Yaskawa Electric
Yposkesi

PRICING DETAILS

Single-User License USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

One Location Site License USD 7,999

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

Department License USD 10,599

This license grants the right of use of the purchased report by a department / team of individuals (up to 8) n a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

Enterprise License USD 17,999

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com

Example Insights

Overview

Frequently Asked Questions

Contents

Table Of Contents

List Of Figures

List Of Tables

List Of Companies

PRICING DETAILS

Single-User License USD 5,899

One Location Site License USD 7,999

Department License USD 10,599

Enterprise License USD 17,999

YOU MAY ALSO LIKE

BLOGS

Spatial Genomics, Transcriptomics and Proteomics Solutions - An Amelioration of Tissue Analytics

DNA Cloning Market: A Step Towards Future of Genetics Science

LOGIN

Forgot Password

Market Insights Reports

Indication Specific Reports

Fill Finish Biopharmaceuticals

Example Insights

Overview

Frequently Asked Questions

Contents

Table Of Contents

List Of Figures

List Of Tables

List Of Companies

PRICING DETAILS

Single-User License USD 5,899

One Location Site License USD 7,999

Department License USD 10,599

Enterprise License USD 17,999

YOU MAY ALSO LIKE

SUBSCRIBE TO INDUSTRY UPDATES

Spatial Genomics, Transcriptomics and Proteomics Solutions - An Amelioration of Tissue Analytics

DNA Cloning Market: A Step Towards Future of Genetics Science

This site uses cookies for better browsing experienceAccept